Abstract:This working paper is hosted by The Berkeley Electronic Press (bepress) and may not be commercially reproduced without the permission of the copyright holder. Summary. Randomized clinical trials are a powerful tool for investigating causal treatment effects, but in human trials there are oftentimes problems of noncompliance which standard analyses, such as the intention-to-treat or as-treated analysis, either ignore or incorporate in such a way that the resulting estimand is no longer a causal effect. One alternative to these analyses is the complier average causal effect (CACE) which estimates the average causal treatment effect among a subpopulation that would comply under any treatment assigned. We focus on the setting of a randomized clinical trial with crossover treatment noncompliance (e.g., control subjects could receive the intervention and intervention subjects could receive the control) and outcome nonresponse. In this article, we develop estimators for the CACE using multiple imputation methods, which have been successfully applied to a wide variety of missing data problems, but have not yet been applied to the potential outcomes setting of causal inference. Using simulated data we investigate the finite sample properties of these estimators as well as of competing procedures in a simple setting. Finally we illustrate our methods using a real randomized encouragement design study on the effectiveness of the influenza vaccine. 1. Introduction The focus of empirical studies in medicine is often to estimate the causal effect of treatments, where randomized clinical trials are considered the most acceptable tool for investigating these causal relationships. But in trials involving human subjects there are oftentimes problems of patient noncompliance, where the patient does not adhere to the treatment assigned. In addition, there is also the problem of nonignorable missing data, where the missing-data mechanism may depend on unobserved data. Standard methods and analyses either ignore these complications, which can lead to biased estimates of causal treatment effect, or account for them in such a way that the resulting estimand can no longer be considered a causal effect of treatment. A statistical framework for causal inference that deals with the issue of noncompliance is based on potential outcomes and was first introduced by Neyman (1923) for randomized studies and later developed by Rubin (1974, 1978) for nonrandomized studies and other forms of inference. Rubin's approach, sometimes referred to as the Ru-bin Causal Model (Holland, 1986), provides a framework for defining the parameters of interest and correctly attributing the …

Locally Efficient Estimation of Marginal Treatment Effects When Outcomes Are Correlated: Is the Prize Worth the Chase?

How to relate potential outcomes: Estimating individual treatment effects under a given specified partial correlation

The covariate-adjusted residual estimator and its use in both randomized trials and observational settings

Identification and estimation of treatment effects on long-term outcomes in clinical trials with external observational data

Translating questions to estimands in randomized clinical trials with intercurrent events

Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach

Effects Among the Affected

Conditional and Unconditional Treatment Effects in Randomized Clinical Trials: Estimands, Estimation, and Interpretation

A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints

Series 2-19-2009 Multiple Imputation Methods for Treatment Noncompliance and Nonresponse in Randomized Clinical Trials

Intent-to-treat Analysis of Cluster Randomized Trials when Clusters Report Unidentifiable Outcome Proportions.

Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone?

Estimands in clinical trials of complex disease processes

A nonparametric relative treatment effect for direct comparisons of censored paired survival outcomes

Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome

Comparing cluster-level dynamic treatment regimens using sequential, multiple assignment, randomized trials: Regression estimation and sample size considerations

A Potential Outcomes, and Typically More Powerful, Alternative to 'Cochran-Mantel-Haenszel'

Competing risks and multivariate outcomes in epidemiological and clinical trial research

Improving efficiency of inference in clinical trials with external control data

Blurring cluster randomized trials and observational studies: Two-Stage TMLE for subsampling, missingness, and few independent units.

Using Targeted Maximum Likelihood Estimation to Estimate Treatment Effect with Longitudinal Continuous or Binary Data: A Systematic Evaluation of 28 Diabetes Clinical Trials